None
No disclosed counterparties: EPAC.
| Stage | EPAC | % of rev | ETN | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $186M | 100.00% | $8.9B | 100.00% | ETN ×48.17 |
| Gross profit | $87M | 47.07% | $3.1B | 34.70% | EPAC +12.4pp |
| Operating income | $34M | 18.48% | $1.6B | 17.76% | EPAC +0.7pp |
| Pre-tax income | $31M | 16.76% | $1.4B | 15.31% | EPAC +1.5pp |
| Net income | $24M | 13.17% | $1.1B | 12.06% | EPAC +1.1pp |
| Stage | EPAC | ETN | Gap · A − B |
|---|---|---|---|
| Revenue | $186M100.00% | $8.9B100.00% | ETN ×48.17 |
| Gross profit | 47.07%$87M | 34.70%$3.1B | EPAC +12.4pp |
| Operating income | 18.48%$34M | 17.76%$1.6B | EPAC +0.7pp |
| Pre-tax income | 16.76%$31M | 15.31%$1.4B | EPAC +1.5pp |
| Net income | 13.17%$24M | 12.06%$1.1B | EPAC +1.1pp |